Secukinumab is the only anti IL-17A inhibitor approved for hidradenitis suppurativa.
The brand-new treatment from Elanco is currently the only approved therapeutic solution proven to treat canine parvovirus.
How much progress have we made in developing therapies to treat this common childhood respiratory disorder?
A combination of dabrafenib with trametinib was approved by the FDA for treatment of pediatric patients 1 year and older with low-grade glioma & BRAF V600E mutation who require systemic therapy.
Evidence of the relationship between probiotics and antibiotics is lacking.
Evidence of the relationship between probiotics and antibiotics is lacking.
Developing innovative solutions for women with depression, accounting for differences in gender and sex, are critically important
Two RSV vaccines for seniors have completed phase 3 trials and demonstrated beneficial results. The public still awaits FDA decisions on potential approvals for both.
A new drug review for vericiguat, indicated for heart failure, reports efficacy and safety data.
Iowa's Department of Health and Human Services, which manages the two health insurers that delivered care to adults and children in the state’s Medicaid program last year, was alleged to provide inadequate mental and behavioral health care to children on Medicaid.
Evidence of the relationship between probiotics and antibiotics is lacking.
Opioid use disorder during pregnancy is stigmatized, but these patients deserve compassionate, nonjudgmental care.
Unfortunately, even though the need for making proper dose adjustments for kidney function is well-recognized, clinicians face many challenges in doing so.
Vaccination greatly reduces the probability of experiencing severe COVID-19 in both variants. Adults between the ages of 40 to 59 years saw the most significant reduction in risk when compared to individuals in other age categories.
Researchers of a new paper discuss the inconsistencies between gene and cell therapy indications and payor coverage.
Part of the risk of developing kidney involvement begins when type 1 diabetes mellitus (T1DM) sets in and establishes itself in the patient, with up to 65% of children experiencing acute kidney injury during T1DM onset, which can further predispose to the development of future chronic kidney disease.
Patients with advanced or recurrent endometrial cancer treated with Keytruda plus chemotherapy had improved progression-free survival compared with chemotherapy alone.
Does anxiety justify an exemption from vaccine mandates among health care workers?
Women with PCOS were more likely to begin fertility treatment with ovulation induction compared to those without PCOS.
Do no harm, even though your patient might.
This past year has seen several important new drug approvals and labeling updates for children. Here is what you should know.
A 1-year observational follow-up of a 3-month randomized controlled trial provides insight into the benefits of advanced hybrid closed-loop system use in people with type 1 diabetes using multiple daily injections and self-monitoring of blood glucose.
Despite telehealth’s rise in popularity during the height of COVID-19, many individuals still aren't aware that it's a viable option.
Pharmacogenetics can inform precision prescribing practices, which in turn can solve the inefficiencies of current prescribing models.
Last August, zuranolone (Zurzuvae) became the first FDA-approved pill to treat postpartum depression in adults.
Spikevax is now the second COVID-19 vaccine approved by regulators.
Stimulant medications are the first-line pharmacologic therapy for ADHD, but many of these medications are currently in short supply.
Research presented at the Heart Failure Society of America 2024 Annual Meeting demonstrated that glucagon-like peptide 1 receptor agonists (GLP-1 RAs) reduced cardiovascular events in patients without diabetes.
Exkivity remains available while Takeda works with the FDA on withdrawal timing, and the company said that patients currently taking the therapy will continue to have access after it is withdrawn.